|
|
|
|
|
N01HR536168 |
ARDS |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NHLBI |
$202,930 |
N01HV448188 |
PEDIATRIC CIRCULATORY SUPPORT |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NHLBI |
$720,328 |
1F32CA117246-01 |
The role of SPARC in prostate cancer growth in bone |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NCI |
$43,976 |
1F32NS052042-01 |
Realistic Biophysical Modeling of Deep Brain Stimulation |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NINDS |
$42,068 |
1K01CA098176-01A2 |
Genetic Determinants of Akt-induced Transformation |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NCI |
$108,000 |
1K01HL080953-01 |
Plasminogen and Metalloproteinases in Granuloma/Fibrosis |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NHLBI |
$97,858 |
1K23DK068112-01A1 |
Genetic Studies in Crohn's Disease |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NIDDK |
$129,060 |
1K23HL081538-01 |
Matrix Metalloproteinases and PPAR Gamma in Sarcoidosis |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NHLBI |
$128,971 |
1K23NS052548-01 |
Overcoming Genetic Heterogeneity in the Epilepsies |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NINDS |
$135,000 |
1K23RR022956-01A1 |
Pilot CMV Prevention Trial in Pediatric Lung Transplant |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NCRR |
$128,860 |
1K24HL077522-01A1 |
Training/Research Center--Bone Marrow Failure Syndromes |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NHLBI |
$96,976 |
1P50HL077107-01 |
Molecular Determinants of Coronary Artery Disease |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NHLBI |
$2,951,393 |
1R01AG025278-01A1 |
Role of sestrin family genes in antioxidant defense |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NIA |
$306,000 |
1R01AG025493-01 |
Roles of Reticulon proteins in neurodegenerative disease |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NIA |
$313,650 |
1R01AI059710-01A2 |
Signaling in Cells Chronically Exposed to Interferons |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NIAID |
$258,749 |
1R01AI060632-01A1 |
SIGIRR A Negative Regulator of Toll-IL-IR Signaling |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NIAID |
$325,125 |
1R01AI060788-01A1 |
Viral Stress-inducible Gene Expression |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NIAID |
$344,250 |
1R01AI065470-01 |
Act1 in CD40-/BAFFR-Mediated B Cell Survival |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NIAID |
$325,125 |
1R01CA100163-01A2 |
Induction of IL-12 in DC by structurally-defined RNA |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NCI |
$241,740 |
1R01CA106415-01A1 |
Inhibition of VEGF Mediated Angiogenesis by TIMP-3 |
CLEVELAND CLINIC LERNER COL/MED-CWRU |
NCI |
$247,161 |